MINIRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Minirin, and when can generic versions of Minirin launch?
Minirin is a drug marketed by Ferring and is included in one NDA.
The generic ingredient in MINIRIN is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minirin
A generic version of MINIRIN was approved as desmopressin acetate by MEITHEAL on October 15th, 1997.
Summary for MINIRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 14 |
Patent Applications: | 498 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MINIRIN at DailyMed |
Recent Clinical Trials for MINIRIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ahmed talaat ahmed aly | Phase 2 |
Children's Hospital of Fudan University | N/A |
Ferring Pharmaceuticals |
Anatomical Therapeutic Chemical (ATC) Classes for MINIRIN
US Patents and Regulatory Information for MINIRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring | MINIRIN | desmopressin acetate | SPRAY, METERED;NASAL | 021333-001 | Sep 16, 2002 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |